Found 8 matching trials
Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia
PHASE1The purpose of this study is to evaluate the safety, pharmacokinetic and ph...
Location
Multiple Locations
Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients
PHASE3The primary objective of this study is to evaluate the time to confirmed cl...
Location
Pinnacle Research Group LLC
A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
PHASE3The main aim of this study is to check if repeated subcutaneous (SC) inject...
Location
Clinical Research Center of Alabama
A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy Subjects
PHASE1The purpose of this study is to assess the safety and tolerability of the s...
Location
Vince and Associates Clinical Research
A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants
PHASE1The purpose of this study is to evaluate the safety, tolerability, and phar...
Location
UC San Diego Health System - La Jolla
Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE
PHASE3This is a phase 3, multicenter, randomized, double-blind, placebo-controlle...
Location
Clinical Research Center of Alabama, LLC
A Study to Determine the Safety, Tolerability, and Pharmacokinetics of Lanadelumab Administered Intravenously in Healthy Adult Volunteer Participants
PHASE1The purpose of this study to evaluate the safety, tolerability and pharmaco...
Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease
PHASE2Bradykinin is a potent vasodilator that is formed by the activation of the ...
Location
Vanderbilt University Medical Center